1023481

OPTINOSE US INC — FEI 3013148088

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 26, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Yardley, PA (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
745321 CFR 312.56(b)Investigator non-compliance